Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development-Reference-Cited by-同舟云学术

Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development

Published:2022-07 Issue:1 Volume:163 Page:77-83
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Mulberg Andrew E.^ORCID,Conklin Laurie S.,Croft Nicholas M.,Parikh Anushree,Bousvaros Athos,DeZoeten Edwin,Dubinsky Marla,Martin Carpi Francisco Javier,Escher Hankje,Vesely Richard,Ollivier Cecile,Crandall Wallace,Hovinga Collin

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary;Turner;Gut,2020

2. European Medicines Agency. ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e11r1-guideline-clinical-investigation-medicinal-products-pediatric-population-revision-1_en.pdf. Accessed December 15, 2021.

3. Impact of drug approval pathways for paediatric inflammatory bowel disease;Crowley;J Crohns Colitis,2022

4. Research into pediatric uses for drugs and biological products. 21 CFR §355c (2010).

5. Expediting drug development for pediatric inflammatory bowel disease: a workshop to identify barriers and move forward;Altepeter;Gastroenterology,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collaborative Registries for Pediatric Crohn's Disease: A Leap Forward or More of the Same?;American Journal of Gastroenterology;2023-12-05

2. The State of Clinical Trials in Pediatric Inflammatory Bowel Disease;Gastroenterology Clinics of North America;2023-09

3. Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2023-02-14

4. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study;The Lancet Gastroenterology & Hepatology;2023-01

5. The Role of Master Protocols in Pediatric Drug Development;Therapeutic Innovation & Regulatory Science;2022-09-01